Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseases.
about
Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice.Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in RatBevacizumab-induced chronic interstitial pneumonia during maintenance therapy in non-small cell lung cancer.The Safety and Efficacy of Treatment with Nab-Paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.
P2860
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carboplatin plus paclitaxel in ...... th interstitial lung diseases.
@en
Carboplatin plus paclitaxel in ...... th interstitial lung diseases.
@nl
type
label
Carboplatin plus paclitaxel in ...... th interstitial lung diseases.
@en
Carboplatin plus paclitaxel in ...... th interstitial lung diseases.
@nl
prefLabel
Carboplatin plus paclitaxel in ...... th interstitial lung diseases.
@en
Carboplatin plus paclitaxel in ...... th interstitial lung diseases.
@nl
P2093
P2860
P356
P1476
Carboplatin plus paclitaxel in ...... th interstitial lung diseases.
@en
P2093
Hidekazu Suzuki
Ichiro Kawase
Kohei Okafuji
Masashi Kobayashi
Motohiro Tamiya
Naoko Morishita
Norio Okamoto
Osamu Morimura
Satomu Morita
Takayuki Shiroyama
P2860
P304
P356
10.3892/MCO.2013.82
P577
2013-03-01T00:00:00Z